Cardiovascular diseases remain the leading cause of death globally, making early detection critical for improving patient outcomes. This article explores how point-of-care testing (POCT) devices are transforming cardiovascular screening by enabling rapid, on-site detection of key biomarkers such as troponin, BNP, D-dimer, and hs-CRP. By significantly reducing turnaround time and supporting real-time clinical decision-making, POCT enhances efficiency in emergency, primary care, and remote settings. Backed by recommendations from leading organizations such as the World Health Organization and American Heart Association, POCT is emerging as a vital tool in preventive cardiology and decentralized healthcare systems.
READ MORE
